Skip to content
healthcare.dev
Get a free key

RYSTIGGO

NDC 50474-980, ROZANOLIXIZUMAB, injection, solution, from UCB, Inc..

Product NDC
50474-980
Status
Listed
Labeler
UCB, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761286
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50474-980 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROZANOLIXIZUMAB140 mg/mL

Pharmacologic classes

Neonatal Fc Receptor Blocker [EPC]; Neonatal Fc Receptor Blockers [MoA]

Package NDCNDC-11Package
50474-980-79504740980791 VIAL, GLASS in 1 CARTON (50474-980-79) / 2 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3c0eb8c2-c042-4954-b451-3baa77f5e6d1

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50474-980

Use it

Look up 50474-980 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50474-980 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50474-980. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.